Tag: Clots
Rate of Venous Thromboembolism Increased With Cancer Surgery
Cause-specific hazard ratio for pulmonary embolism peaked after discharge, then plateaued 60 to 90 days later
Bivalent COVID-19 Shot Effective for Preventing Thromboembolic Events
Findings seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease
Clot Risk High With Oral Contraceptives for Those at Genetic Risk
Risk highest in the first two years, regardless of genetic risk, and lower for continued use
Mechanical Thrombectomy Safe, Effective for High-Risk Pulmonary Embolism
No deaths seen at 30-day follow-up in real-world cohort
Estrogen-Linked Thrombotic Biomarkers Drop After Cessation of Combo Pill
Decreases seen at week 12, with most of the decrease achieved at two and four weeks after cessation of combined hormonal contraceptives
Link Explored for NSAID Use, Hormonal Contraception, VTE Risk
NSAID use positively linked to VTE, with extra VTE events in those with concomitant high-, medium-risk contraception use
Pulmonary Embolism-Related Mortality Remained Unchanged From 2006 to 2019
Age-adjusted mortality rate increased for men versus women and Black versus White patients
Prolonged Direct Oral Anticoagulants Beneficial for Preventing Recurrent VTE
Findings seen among adults prescribed warfarin, DOACs beyond six months after acute venous thromboembolism
New Eligibility Criteria May Increase Endovascular Thrombectomy Rates
Findings based on several criteria in patients with ischemic stroke due to anterior circulation large vessel occlusions
Concerning CT Findings Increase Health Care Utilization With Low-Risk Pulmonary Embolism
However, no short-term adverse clinical outcomes seen for these patients versus low-risk patients without concerning findings